Coya Therapeutics, Inc. ( COYA) - Key Metrics
COYA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.24 | -$0.34 | -$682.56 | -$682.56 |
| 2025Q3 | $0.21 | -$0.13 | -$0.07 | -$0.07 |
| 2025Q2 | $0.01 | -$0.36 | -$0.35 | -$0.35 |
| 2025Q1 | $0.02 | -$0.44 | -$0.17 | -$0.17 |
COYA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -4.25 |
| 2025Q3 | ? | -11.27 |
| 2025Q2 | ? | -3.94 |
| 2025Q1 | ? | -3.70 |
COYA
Price: $4.25
52 week price:
Earnings Per Share: -1.15 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Market Capitalization: 106.7 million